Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ZASTROW BIOENERGI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   0.7% 1.3% 1.0% 0.6% 0.6% 1.5% 7.6% 7.4%   Credit score (0-100)   96 81 86 98 96 75 32 33   Credit rating   AA A A AA AA A BB BB   Credit limit (kDKK)   2,236.5 227.8 680.1 2,636.0 4,716.8 111.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   8,920 4,648 5,103 15,742 25,690 6,659 0.0 0.0   EBITDA   8,920 4,241 4,299 14,520 23,692 4,859 0.0 0.0   EBIT   5,553 657 618 10,672 19,229 -702 0.0 0.0   Pre-tax profit (PTP)   4,496.8 -126.7 125.4 10,209.0 19,055.2 -824.5 0.0 0.0   Net earnings   3,507.5 -100.8 97.8 7,963.0 14,947.5 -580.5 0.0 0.0   Pre-tax profit without non-rec. items   4,497 -127 125 10,209 19,055 -824 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   33,599 31,681 29,564 26,573 36,356 37,455 0.0 0.0   Shareholders equity total   16,800 15,699 10,797 18,760 31,708 29,127 29,027 29,027   Interest-bearing liabilities   15,941 13,563 14,821 5,645 1,682 8,401 0.0 0.0   Balance sheet total (assets)   43,516 40,477 35,572 35,537 53,419 47,543 29,027 29,027   Net Debt   10,338 13,563 13,626 4,355 -6,978 5,022 -29,027 -29,027     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   8,920 4,648 5,103 15,742 25,690 6,659 0.0 0.0   Gross profit growth   -58.7% -47.9% 9.8% 208.5% 63.2% -74.1% -100.0% 0.0%   Employees   0 1 2 3 3 3 0 0   Employee growth %   0.0% 0.0% 100.0% 50.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   43,516 40,477 35,572 35,537 53,419 47,543 29,027 29,027   Balance sheet change%   14.1% -7.0% -12.1% -0.1% 50.3% -11.0% -38.9% 0.0%   Added value   8,920.0 4,241.5 4,299.3 14,520.3 23,076.9 4,859.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -741 -5,503 -5,799 -6,839 5,320 -4,462 -37,455 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   62.3% 14.1% 12.1% 67.8% 74.8% -10.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.6% 1.6% 1.6% 30.0% 43.2% -1.4% 0.0% 0.0%   ROI %   15.2% 1.8% 1.9% 35.5% 57.5% -1.8% 0.0% 0.0%   ROE %   23.3% -0.6% 0.7% 53.9% 59.2% -1.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   38.6% 38.8% 30.4% 52.8% 59.4% 61.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   115.9% 319.8% 316.9% 30.0% -29.5% 103.3% 0.0% 0.0%   Gearing %   94.9% 86.4% 137.3% 30.1% 5.3% 28.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.5% 5.3% 3.5% 4.5% 4.7% 2.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.6 0.3 0.7 0.9 0.6 0.0 0.0   Current Ratio   1.0 0.9 0.5 0.8 1.0 0.7 0.0 0.0   Cash and cash equivalent   5,603.2 0.0 1,195.7 1,289.8 8,660.0 3,379.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -117.1 -620.3 -6,543.7 -2,116.4 -212.7 -4,569.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 4,241 2,150 4,840 7,692 1,620 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 4,241 2,150 4,840 7,897 1,620 0 0   EBIT / employee   0 657 309 3,557 6,410 -234 0 0   Net earnings / employee   0 -101 49 2,654 4,982 -193 0 0